Prothena Historical Income Statement
| PRTA Stock | USD 16.01 4.06 33.97% |
Historical analysis of Prothena Plc income statement accounts such as Other Operating Expenses of 296.5 M, Research Development of 231.6 M, Cost Of Revenue of 231.6 M or Total Operating Expenses of 296.5 M can show how well Prothena plc performed in making a profits. Evaluating Prothena Plc income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Prothena Plc's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Prothena plc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Prothena plc is a good buy for the upcoming year.
Prothena |
About Prothena Income Statement Analysis
Prothena plc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Prothena Plc shareholders. The income statement also shows Prothena investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Prothena Plc Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Prothena plc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Prothena plc. It is also known as Prothena Plc overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on Prothena Plc income statement and is an important metric when analyzing Prothena plc profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Most accounts from Prothena Plc's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Prothena plc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.At present, Prothena Plc's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 95.9 M, whereas Depreciation And Amortization is forecasted to decline to about 881.6 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 128.6M | 185.5M | 282.4M | 296.5M | Cost Of Revenue | 82.3M | 6.7M | 220.6M | 231.6M |
Prothena Plc income statement Correlations
Click cells to compare fundamentals
Prothena Plc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Prothena Plc income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | (122K) | 7.0M | 6.8M | 744K | 928K | 881.6K | |
| Interest Expense | 8.2M | 8.3M | 6.7M | 6.7M | 7.7M | 8.1M | |
| Selling General Administrative | 35.7M | 38.7M | 46.3M | 49.9M | 61.8M | 34.6M | |
| Total Revenue | 814K | 853K | 200.6M | 53.9M | 91.4M | 95.9M | |
| Gross Profit | (50.0M) | 853K | 200.6M | 53.9M | (129.2M) | (122.7M) | |
| Other Operating Expenses | 86.6M | 113.6M | 128.6M | 185.5M | 282.4M | 296.5M | |
| Operating Income | (85.7M) | (112.7M) | 72.0M | (131.6M) | (191.0M) | (181.5M) | |
| Ebit | (85.7M) | (112.7M) | 72.0M | (131.6M) | (191.0M) | (181.5M) | |
| Research Development | 50.8M | 74.9M | 82.3M | 135.6M | 220.6M | 231.6M | |
| Ebitda | (85.8M) | (105.8M) | 78.8M | (130.8M) | (190.1M) | (180.6M) | |
| Cost Of Revenue | 50.8M | 74.9M | 82.3M | 6.7M | 220.6M | 231.6M | |
| Total Operating Expenses | 86.6M | 113.6M | 128.6M | 185.5M | 282.4M | 296.5M | |
| Income Before Tax | (77.3M) | (111.4M) | 71.9M | (125.6M) | (160.5M) | (152.5M) | |
| Net Income | (77.7M) | (111.1M) | 67.0M | (116.9M) | (147.0M) | (139.7M) | |
| Income Tax Expense | 379K | (283K) | 4.9M | (8.7M) | (13.5M) | (12.8M) | |
| Total Other Income Expense Net | 8.4M | 1.3M | (54K) | 6.0M | 30.6M | 32.1M | |
| Net Income From Continuing Ops | (77.7M) | (111.1M) | 67.0M | (116.9M) | (147.0M) | (139.7M) | |
| Non Operating Income Net Other | 48K | 196K | (62K) | (96K) | (86.4K) | (90.7K) | |
| Net Income Applicable To Common Shares | (77.7M) | (111.1M) | 67.0M | (116.9M) | (105.3M) | (110.5M) | |
| Tax Provision | 379K | (283K) | 4.9M | (8.7M) | (13.5M) | (12.8M) | |
| Interest Income | 8.2M | 1.4M | 42K | 6.3M | 31.0M | 32.6M | |
| Net Interest Income | 8.2M | 1.4M | 42K | 6.3M | 31.0M | 32.6M | |
| Reconciled Depreciation | 6.8M | 7.0M | 6.8M | 744K | 928K | 881.6K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Prothena plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Prothena Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prothena Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prothena Plc Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.46) | Revenue Per Share 2.482 | Quarterly Revenue Growth (0.99) | Return On Assets (0.16) | Return On Equity (0.23) |
The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prothena Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.